Showing results (1911-1920 of 2,286) with videos related to
Sort By:
Pageof 229
IEEE Journal of Biomedical and Health Informatics|June 22, 2023
Artifact-Tolerant Clustering-Guided Contrastive Embedding Learning for Ophthalmic Images in GlaucomaMin Shi, Anagha Lokhande, Mojtaba S Fazli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Optimizing a novel regional chemotherapeutic agent against melanoma: hyperthermia-induced enhancement of temozolomide cytotoxicitySae Hee Ko, Tomio Ueno, Yasunori Yoshimoto, et al.Ophthalmic Epidemiology|April 9, 2009
Rationale, design, methodology, and baseline data of a population-based study in rural China: the Handan Eye StudyYuan Bo Liang, David S Friedman, Tien Yin Wong, et al.British Journal of Cancer|September 15, 2012
Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumoursA O von Bueren, M D Bacolod, C Hagel, et al.Frontiers in Oncology|March 18, 2021
Adjuvant Radiation in Older Patients With Glioblastoma: A Retrospective Single Institution AnalysisJessica W Lee, John P Kirkpatrick, Frances McSherry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium studySridharan Gururangan, Susan N Chi, Tina Young Poussaint, et al.American Journal of Ophthalmology|September 15, 2004
Risk assessment in the management of patients with ocular hypertensionRobert N Weinreb, David S Friedman, Robert D Fechtner, et al.Cancer Chemotherapy and Pharmacology|January 29, 1999
Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR)Q Dong, S P Johnson, O M Colvin, et al.Cancer Medicine|May 2, 2013
Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastomaEmil Lou, Katherine B Peters, Ashley L Sumrall, et al.Molecular Cancer Therapeutics|October 17, 2006
Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant gliomaJill A Maxwell, Stewart P Johnson, Jennifer A Quinn, et al.Pageof 229